ACRO Biomedical Co., Ltd. (6748.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$181.00 (-2.16%) as of
Key statistics
- Market cap
- 12.97B
- EPS (TTM)
- -1.18
- Dividend yield
- 0.00%
- 52-week range
- 57.30 – 310.00
- Beta
- 0.19
- Revenue (TTM)
- 52.76M
- Profit margin
- -149.34%
- Volume
- 215.08k
About ACRO Biomedical Co., Ltd.
ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally. The company engages in manufacturing medical devices and cosmetics; research, design, production, and sales of biological tissue implants; and dental and orthopedic implants, collagen, and related derivative products. It also offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. ACRO Biomedical Co., Ltd. was founded in 2014 and is based in Kaohsiung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Kaohsiung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.